Mouse hybridomas were isolated by fusing P3-X63-Ag 8.653 myeloma cells with spleen cells from mice that had been repeatedly immunized with Legionella penumophila serogroup 1 organisms. In one fusion, three independent hybridoma cultures which secreted antibodies that reacted with the immunizing strain in the indirect immunofluorescent-antibody test were selected for cloning. Representative continuously growing clones, one of each hybridoma, which remained stable in producing high-titer antibodies were examined in detail. Extensive specificity tests revealed that these hybridoma-derived monoclonal antibodies were specifically directed against L. pneumophila serogorup 1 organisms and showed no cross-reactions in the indirect immunofluorescent-antibody test either with the other known serogroups of L. pneumophila or with other unrelated bacterial species. The three monoclonal antibodies F4/CB5/K18, F/4/CB5/K1O4, and F4/JD3.8/K1O1 belonged to the immunoglobulin M class and were capable of agglutinating serogroup 1 organisms of L. pneumophila exquisitely. These monoclonal antibodies against L. pneumophila with defined fine specificity should enable purification and subsequent analysis of the corresponding antigenic determinant(s) and can also be used for the preparation of unlimited supplies of standard diagnostic reagents for the identification of L. pneumophila in the tissues and body fluids.
Legionella pneumophila, a gram-negative bacterium (1), was first recognized as the etiological agent of Legionnaires disease, an acute human illness primarily manifested as severe pneumonia with a high fatality rate (13) . A second major clinical syndrome, Pontiac fever, is a nonpneumonic, mild, and self-limited respiratory illness (6) . Since the discovery of this bacillus, the indirect immunofluorescent-antibody (IF) test has been used extensively in the serodiagnosis of legionellosis (19, 20) , and the direct fluorescent-antibody test carried out with conjugated antisera provided by the Centers for Disease Control, Atlanta, Ga., has been employed in detecting organisms in biopsy and postmortem lung tissues and body fluids (13) . Serological studies have led to the identification of at least 6 serogroups of L. pneumophila, with evidence of cross-reactivity among them (14, 20) . Two-dimensional (crossed) immunoelectrophoresis carried out with antisera prepared in rabbits against whole bacteria has revealed the existence of distinctive group-specific antigens among serogroups 1, 2, 3, and 4 and also a minimum of 27 common antigens among a total of 31 which could be identified by this procedure (9) . With the aid of elaborate conventional chemical methods, it has been possible to extract a serogroup 1-specific (5, 8, 21) and a crossreactive (21) antigenic component of L. pneumophila.
To isolate pure antigenic molecules of L. pneumophila which are of critical importance in the pathological process and in protection against legionellosis, it will be useful to produce monoclonal antibodies against relevant components and to use these antibodies to isolate individual molecules from antigenically complex L. pneumophila by immunosorbent chromatography. This Preparation of antigens. The various bacterial strains were grown on Mueller-Hinton agar (4) at 37°C in a candle extinction jar, and the growth was harvested in sterile distilled water. After repeated washings, bacteria were suspended either in 2.5 ml of 2% (vol/vol) neutral Formalin and were kept overnight at room temperature or were incubated in a boiling-water bath for 30 min. Charcoal-yeast extract plates inoculated with these preparations remained sterile. Both Formalin-treated and heat-treated bacterial suspensions were centrifuged, and the pellets were suspended in phospate buffered saline to give turbid stock suspensions which were stored at 4°C until use.
Immunization. Adult female BALB/c mice were immunized with L. pneumophila serogroup 1 (Philadelphia strain). Mice were injected intraperitoneally with bacterial suspension (0.2 ml per mouse; 109 bacteria) emulsified in incomplete Freund adjuvant (1:1, vol/vol). This was followed by three intraperitoneal booster injections of the antigen (>109 bacteria per injection) without adjuvant over a period of 3 to 4 months. The last injection was given 3 days before sacrificing the mice to obtain spleen cells for fusion purposes.
Mouse myeloma cells. P3-X63-Ag8.653, an 8-azaguanine-resistant and nonproducer tissue culture line, was obtained from G. J. Hammerling (Institut fur Genetik, Universitat Koln, Cologne, West Germany). This line is a variant derived from P3-X63-Ag8, which represents a subline of the BALB/c myeloma MOPC21 and secretes a lk immunoglobulin (7) . By virtue of its deficiency in the enzyme hypoxanthine guanine phosphoribosyltransferase, the P3-X63-Ag8.653 line is killed in hypoxanthine-aminopterine-thymidine (HAT) medium (12) . This line was maintained in RPMI 1640 medium (Flow Laboratories, McLean, Va.) supplemented with 2 mM L-glutamine, 20% fetal calf serum, 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml (RPMI-FCS).
Cell fusion, cloning, and maintenance of cells. (Table 3) . Furthermore, when hybridoma cells were internally labeled with [35S]methionine and the culture supernatants were precipitated with total anti-mouse immunoglobulin serum and then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, each of the three monoclonal antibodies was found to secrete mu chains. In the presence of each of the three monoclonal antibodies, bHeated at 100°C for 20 min.
In conclusion, this report describes the establishment of three cloned hybridoma cell lines producing IgM monoclonal antibodies against serogroup 1 organisms of L. pneumophila. These monoclonal antibodies are useful reagents for rapid diagnostic assays in clinical laboratories based on direct antigen detection in body fluids and tissues and will also permit early identification of cultures belonging to serogroup 1, which accomodates most of the clinical isolates. In addition, they are of potential value in the purification and subsequent characterization of the serogroup 1-specific molecules of L. pneumophila.
